Last updated: July 12, 2026

Application No. 19/361,525

Untitled Application

Unknown

Filed

Priority

Oct 21, 2024 — provisional 63/709,816 +4 more

Examiner

MARVICH, MARIA

Art Unit

Tech Center

PharmaEssentia Corporation

Assignee

Pharmaessentia Corporation

OA Round

1 (Non-Final)

This examiner grants 55% of cases after interview

— +27.6% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 978 resolved cases, 2023–2026

Examiner Intelligence

MARVICH, MARIA View full profile →

Grants 55% of resolved cases

Career Allowance Rate

535 granted / 978 resolved

-5.3% vs TC avg

Strong +28% interview lift

Without

With

+27.6%

Interview Lift

resolved cases with interview

Typical timeline

4y 0m

Avg Prosecution

38 currently pending

Career history

1027

Total Applications

across all art units

Statute-Specific Performance

§101

2.2%

-37.8% vs TC avg

§103

39.7%

-0.3% vs TC avg

§102

13.9%

-26.1% vs TC avg

§112

17.8%

-22.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 978 resolved cases

Precedent Cases

Applications granted by this same examiner with similar technology

17/614,327

Patent 12668814

ENGINEERED MUSCLE TARGETING COMPOSITIONS

4y 7m to grant Granted Jun 30, 2026

16/594,017

Patent 12661381

Methods for the Delivery of Therapeutic Agents to Donor Organs

6y 8m to grant Granted Jun 23, 2026

17/358,904

Patent 12655448

HELPER-DEPENDENT ADENOVIRAL GENE THERAPY DELIVERY AND EXPRESSION SYSTEM

4y 11m to grant Granted Jun 16, 2026

16/758,990

Patent 12644137

MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES

6y 1m to grant Granted Jun 02, 2026

17/559,538

Patent 12642869

REGULATABLE ADENO-ASSOCIATED VIRUS (AAV) VECTOR

4y 5m to grant Granted Jun 02, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

55%

Grant Probability

82%

With Interview (+27.6%)

4y 0m

Median Time to Grant

Low

PTA Risk

Based on 978 resolved cases by this examiner. Grant probability derived from career allowance rate.